Delivery Order SPE2DB20D1100-SPE2DB25FE6J5
Award Date 9/12/25
Potential Completion Date 10/3/25
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,711.95 to AmerisourceBergen Drug Corp for ENVARSUS XR 4 MG tablets (100-count units), with an ultimate completion date of August 25, 2025. This is a firm fixed price, non-set-aside delivery order issued under a competitively awarded contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,106.80 by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, with an ultimate completion date of September 24, 2025. The order is for ENVARSUS XR 1 mg tablets in a 30-count supply. This is a firm fixed-price, non-set-aside contract with performance at the company's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,423.90 to AmerisourceBergen Drug Corp for ENVARSUS XR 4 mg tablets (100 count) on September 3, 2025, with completion scheduled for September 24, 2025. This firm fixed-price delivery order was issued competitively with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,711.95 firm-fixed-price contract is for the delivery of ENVARSUS XR 4 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of July 25, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of ENVARSUS XR 4 MG TABLET 100S. The award, valued at $7,194.16, is a firm fixed price contract with an ultimate completion date of October 2, 2024. The contract has no set-aside designation. AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of medical supplies and prescription drugs to support military...
- The Defense Logistics Agency awarded a delivery order valued at $1,169.76 to AmerisourceBergen Drug Corp for ENVARSUS XR 0.75 mg tablets (30-count package) on August 14, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price delivery order represents a non-competitive procurement and is performed at the contractor's Conshohocken, Pennsylvania location. ENVARSUS XR is a tacrolimus-based immunosuppressant medication used in transplant and other immunological...
- The Defense Logistics Agency awarded a $1,711.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Envarsus XR 4 mg tablets (100-count units). This is a non-set-aside competitive award with an ultimate completion date of September 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran...
- The Department of Defense's Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract to AmerisourceBergen Drug Corp in the amount of $1,615.33 for the supply of ENVARSUS XR 4 MG TABLET 100S. The contract has an ultimate completion date of October 10, 2024. AmerisourceBergen, a major pharmaceutical distributor, is supplying this critical medication under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ENVARSUS XR 1 MG TABLET 100S. The contract has a potential value of $1,216.11 and a completion date of February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is issued under an indefinite delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,288.86 to AmerisourceBergen Drug Corp for the supply of Envarsus XR 1 mg tablets (100-count packaging). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle supporting military healthcare programs globally through December 2026....